Development of mass spectrometric methods for tissue imaging and LC-based quantification of glycosphingolipids/gangliosides including Tay-Sachs disease based neuraminidase-deficient mouse models and human gut microbiota
Gespeichert in:
| Keine Beschreibung verfügbar. |